Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3458053 Title: UTILISATION DU RILUZOLE, DE PROMÉDICAMENTS DU RILUZOLE OU D'ANALOGUES DU RILUZOLE AVEC DES IMMUNOTHÉRAPIES POUR TRAITER LES CANCERS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
178003109
WO application number:
US2017033688
Type:
European patent granted for BE
Status:
Open
Publication number:
3458053
WO publication number:
WO2017201501
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
19/05/2017
Grant date:
08/12/2021
EP publication date:
27/03/2019
WO publication date:
23/11/2017
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
08/12/2021
EP B1 publication date:
08/12/2021
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
19/05/2037

Applicant

1

Name:
Biohaven Therapeutics Ltd.
Legal Form:
From:
14/02/2022
Address:
215 Church Street, New Haven, CT 06510, United States (US)
To:

2

Name:
Biohaven Pharmaceutical Holding Company Ltd.
Legal Form:
From:
08/12/2021
Address:
234 Church Street Suite 301, New Haven, CT 06520, United States (US)
To:
14/02/2022

Agent

Name:
POLVERARI Luca
Legal Form:
From:
02/02/2022
Address:
44, rue de la Vallée B.P. 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

Name:
CORIC, Vladimir
Legal Form:
Address:
New Haven Connecticut 06520, United States (US)

Priority

Priority patent number:
201662339433 P
Priority date:
20/05/2016
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 31/428; C07D 277/82; A61P 35/00;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2021/23
Publication date:
19/01/2022
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
CO
Journal edition number:
2022/05
Publication date:
04/04/2022
Description:
Contains data concerning registered assignments or changes of the names of applicants and holders

European Patent Bulletin

1

Issue number:
202149
Publication date:
08/12/2021
Description:
Grant (B1)

2

Issue number:
202150
Publication date:
15/12/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Deed

Change of owner(s)

Change Kind / Decision Type:
Assignment
Deed number:
RC2022000088A
Registration date:
14/02/2022
License effective date:
License expiration date:
Scope of license:
Deed filer:
MARKS & CLERK LLP , MARKS & CLERK LLP , POLVERARI Luca
Bulletin edition number:
Text:
Country code:
Updated license number:
Terminated license number:

Removed pledgee

Name:
Address:

Changed pledgee

Name:
Address:

Removed usufructuary

Name:
Address:

Added usufructuary

Name:
Address:

Changed usufructuary

Name:
Address:

Annual fee

Annual fee(s) Due Date:
01/06/2026
Annual fee number:
10
Annual fee amount:
185 Euro
Expected payer:
Last annual fee payment date:
10/04/2025
Last annual fee paid number:
9
Last annual fee paid amount:
165 Euro
Payer:
C.P.A.
Filing date Document type Publication Type Document Description Number of pages File Type
14/02/2022 Outgoing Correspondence 1 PDF /9/6/7/5/8/0722185769/docs/178003109_0_outgoingcorrespondence_20220215_084700771.pdf
02/02/2022 Outgoing Correspondence 1 PDF /9/6/7/5/8/0722185769/docs/178003109_1_outgoingcorrespondence_20220203_084647720.pdf
02/02/2022 General Document Declaration of domicile 1 PDF /9/6/7/5/8/0722185769/docs/178003109_2_generaldocument_20220203_084647927.pdf
11/03/2022 Request For Change Letter of regularisation of a change 6 PDF /9/6/7/5/8/0722185769/docs/178003109_3_rfc_20220312_084612226.pdf
14/02/2022 General Document Form EP 2544 6 PDF /9/6/7/5/8/0722185769/docs/178003109_4_generaldocument_20220215_084700995.pdf
14/02/2022 Request For Change Letter and/or Form requesting a change in the Register 6 PDF /9/6/7/5/8/0722185769/docs/178003109_5_rfc_20220216_023501290.pdf
11/03/2022 Request For Change EPO Form 2544 2 PDF /9/6/7/5/8/0722185769/docs/178003109_6_rfc_20220312_084612422.pdf
11/03/2022 Request For Change Letter and/or Form requesting a change in the Register 3 PDF /9/6/7/5/8/0722185769/docs/178003109_7_rfc_20220312_084612610.pdf
11/03/2022 Incoming Correspondence (Email) Cover letter 1 PDF /9/6/7/5/8/0722185769/docs/178003109_8_incomingcorrespondenceelectronic_20220312_084613133.pdf
11/03/2022 Outgoing Correspondence 1 PDF /9/6/7/5/8/0722185769/docs/178003109_9_outgoingcorrespondence_20220312_084612063.pdf
02/02/2022 Incoming Correspondence (Email) Cover letter 1 PDF /9/6/7/5/8/0722185769/docs/178003109_10_incomingcorrespondenceelectronic_20220203_084648196.pdf
14/02/2022 Incoming Correspondence (Email) Cover letter 1 PDF /9/6/7/5/8/0722185769/docs/178003109_11_incomingcorrespondenceelectronic_20220215_084701226.pdf